Managed Health Care

Pre-open movers US stock futures are flat this morning after China's central bank raised interest rates. Futures on the Dow Jones Industrial Average rose 9 points to 12,117 and S&P 500 futures dropped 0.60 point to 1,315. Nasdaq 100 futures gained 0.50 point to 2,345.50. A Peek Into Global...

JP Morgan has raised the price target on Aetna, Inc. (NYSE: AET) from $38 to $43 and maintains its Overweight rating.

St. Louis, Missouri-based Centene Corporation (NYSE: CNC) announced on Tuesday morning that it beat consensus Wall Street estimates. Centene Corporation reported that its 4th quarter net earnings rose to $25.4 million, or 50 cents per share, up from $23.7 million, or 53 cents per share, a year...

Coventry Health (NYSE: CVH) reports its Q4 EPS at $1.01, beating the consensus of $0.88. CVH reports its Q4 revenue at $3.03 billion, versus the consensus of $3.01 billion. CVH shares gained 0.26% to $31.42 in after-hours trading. Read more from Benzinga's Company news.

US stock futures are flat this morning after China's central bank raised interest rates. Futures on the Dow Jones Industrial Average rose 5 points to 12,113.00 and S&P 500 futures dropped 0.20 point to 1,315.60. Nasdaq 100 futures gained 0.50 point to 2,345.50. US stocks closed higher, with...

Bethesda, Maryland-based Coventry Health Care, Inc. (NYSE: CVH) on Tuesday morning released financial results that beat Wall Street expectations. Coventry Health Care, Inc reported that its 4th quarter net earnings rose to $150.3 million, or $1.01 per share, up from $109.1 million, or 74 cents per...

Centene Corp (NYSE: CNC) reports its Q4 EPS at $0.50, versus the consensus of $0.48. CNC reports its Q4 revenue at $1.18 billion, versus the consensus of $1.13 billion. CNC shares fell 0.68% to close at $27.75 yesterday. Read more from Benzinga's Company news.

Coventry Health Care Inc (NYSE: CVH) is expected to post its Q4 earnings at $0.88 per share on revenue of $3.01 billion. Walt Disney (NYSE: DIS) is projected to report its earnings at $0.56 per share on revenue of $10.52 billion in first quarter. McClatchy Co (NYSE: MNI) is expected to post its Q4...

Cusick's Corner This market continued to hold up into the close with most of the major averages closing near the highs. However, there was some notable weakness in the Small Caps, IWM, which is a development to keep an eye on. I have referred to these high beta Small Caps as the proverbial canary...

Cusick's Corner What a weekend -- the title is back in the rightful city Green Bay (yes, I am a Packer fan)! There was no denying the 6th seed, they found a way to win on the road against all odds, not listening to the pundits or crying about their injuries (3 starters out in the first half of...

Tenet Healthcare Corporation (NYSE: THC) and Aetna (NYSE: AET) announced today that they have signed a new multi-year agreement. Under this agreement, which took effect January 1, 2011, members of Aetna commercial and Medicare Advantage health plans will be able to continue receiving covered...

Citigroup has published a research report on Humana Inc. (NYSE: HUM) after the company reported a "messy" 4Q. In the report, Citigroup writes "Earnings in the fourth quarter were $0.63 per share, $0.18 below consensus, mainly because of a $139 million ($0.51 per share) reserve charge related to a...

Deutsche Bank has published a research report on Humana, Inc. (NYSE: HUM) after the company reported 4Q EPS results that came in below consensus estimates. In the report, Deutsche Bank writes "The 4Q EPS includes approx $1.02 of primarily one-time expenses, including $0.52 of reserve strengthening...

Goldman Sachs is out with a research report this morning, where it upgrades shares of Aetna (NYSE: AET) to Buy, from Neutral; it has a $44.00 price target on the stock, up from $37.00. The GS analysts said that they are upgrading Aetna to Buy from Neutral, reflecting their now-higher view of 2011-...

Goldman Sachs is upgrading Aetna (NYSE: AET) to Buy from Neutral, reflecting its higher view of 2011-12 EPS and a new PT of $44, implying 18% upside. Goldman is also downgrading UnitedHealth to Neutral from Buy, reflecting less upside to the price target after recent outperformance, as well as...